Cargando…
558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The American Society of Gene Therapy. Published by Elsevier Inc.
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130047/ http://dx.doi.org/10.1016/j.ymthe.2004.06.485 |
| _version_ | 1783516922750435328 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7130047 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2004 |
| publisher | The American Society of Gene Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71300472020-04-08 558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus Mol Ther Infectious Diseases and Vaccines The American Society of Gene Therapy. Published by Elsevier Inc. 2004-05 2016-12-14 /pmc/articles/PMC7130047/ http://dx.doi.org/10.1016/j.ymthe.2004.06.485 Text en Copyright © 2004 The American Society of Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Infectious Diseases and Vaccines 558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus |
| title | 558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus |
| title_full | 558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus |
| title_fullStr | 558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus |
| title_full_unstemmed | 558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus |
| title_short | 558. Anti-SARS Humoral and Cellular Immunity Evoked by an Adenovirus Vector Expressing Spike Glycoprotein from SARS Coronavirus |
| title_sort | 558. anti-sars humoral and cellular immunity evoked by an adenovirus vector expressing spike glycoprotein from sars coronavirus |
| topic | Infectious Diseases and Vaccines |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130047/ http://dx.doi.org/10.1016/j.ymthe.2004.06.485 |